XML 60 R46.htm IDEA: XBRL DOCUMENT v3.25.4
Share-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2025
Share-Based Payment Arrangement [Abstract]  
Schedule of Compensation Expense and Related Income Tax Benefit
The compensation expense from the Company’s share-based compensation plans and associated income tax benefit, excluding the effects of excess tax benefits or shortfalls, are included in the Consolidated Statements of Operations as follows (in millions):
 Year Ended December 31,
Compensation costs and related income tax benefit202520242023
Cost of sales$12 $$
Selling and marketing36 27 16 
Research and development51 36 25 
General and administration76 38 19 
Total compensation expense$175 $110 $66 
Income tax benefit$29 $18 $13 
Schedule of Restricted and Performance Stock-settled Awards
A summary of the Company’s restricted and performance stock-settled awards for the years ended December 31, 2025, 2024 and 2023 is as follows:

Year Ended December 31, 2025
RSUsPSUs
UnitsWeighted-Average Grant Date Fair ValueUnitsWeighted-Average Grant Date Fair Value
Outstanding at beginning of year482,067 $295.39 241,946 $304.44 
Granted360,927 292.50 98,404 306.77 
Released(221,552)298.86 (65,647)362.95 
Forfeited
(17,643)296.72 (2,379)292.45 
Outstanding at end of year603,799 $292.35 272,324 $291.28 

Year Ended December 31, 2024
RSUsPSUs
UnitsWeighted-Average Grant Date Fair ValueUnitsWeighted-Average Grant Date Fair Value
Outstanding at beginning of year437,379 $299.19 195,932 $334.59 
Granted277,390 309.99 88,029 309.05 
Released(210,972)322.67 (35,597)482.42 
Forfeited(21,730)293.83 (6,418)304.52 
Outstanding at end of year482,067 $295.39 241,946 $304.44 

Year Ended December 31, 2023
RSUsPSUs
UnitsWeighted-Average Grant Date Fair ValueUnitsWeighted-Average Grant Date Fair Value
Outstanding at beginning of year242,732 $404.19 105,928 $406.89 
Granted336,168 260.31 104,620 258.57 
Released(95,837)412.47 (64)482.42 
Forfeited(45,684)332.66 (14,552)313.74 
Outstanding at end of year437,379 $299.19 195,932 $334.59